|
Market Closed -
Japan Exchange
02:30:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 2,440.50 JPY | +1.33% |
|
+1.01% | +12.34% |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| 07-30 | Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1,132B 7.1B 6.13B 5.75B 5.24B 9.85B 679B 9.99B 67.44B 26.43B 340B 26.67B 26.09B | P/E 2027 * |
15.7x | P/E 2028 * | 17.9x |
|---|---|---|---|---|---|
| Enterprise Value | 931B 5.84B 5.04B 4.73B 4.31B 8.1B 558B 8.21B 55.45B 21.73B 280B 21.93B 21.45B | EV / Sales 2027 * |
2.04x | EV / Sales 2028 * | 1.97x |
| Free-Float |
80.98% | Yield 2027 * |
3.25% | Yield 2028 * | 3.22% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | +1.33% | ||
| 1 week | +1.01% | ||
| Current month | +2.37% | ||
| 1 month | +1.81% | ||
| 3 months | -0.04% | ||
| 6 months | -4.80% | ||
| Current year | +12.34% |
| 1 week | 2,381.5 |  | 2,449 |
| 1 month | 2,264.5 | | 2,514.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.33% | +1.01% | +44.58% | -11.96% | 7.1B | |
| -0.37% | -3.44% | +14.85% | +65.22% | 47.23B | |
| +0.21% | -1.71% | +51.94% | +122.92% | 39.62B | |
| -0.03% | -2.18% | -8.57% | +15.75% | 12.09B | |
| -1.41% | -6.33% | +13.09% | +72.20% | 11.8B | |
| +0.58% | 0.00% | +30.65% | +148.80% | 9.12B | |
| -0.46% | -0.77% | +22.42% | +40.20% | 7.57B | |
| -1.03% | +1.27% | +16.77% | +200.84% | 6.87B | |
| +0.63% | -2.55% | -30.10% | +23.92% | 5.81B | |
| -0.32% | +5.69% | +37.73% | +109.41% | 4.86B | |
| Average | -0.09% | +0.05% | +19.34% | +78.73% | 15.21B | |
| Weighted average by Cap. | -0.13% | -1.88% | +24.33% | +82.99% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 457B 2.87B 2.48B 2.32B 2.12B 3.98B 274B 4.03B 27.23B 10.67B 137B 10.77B 10.53B | 447B 2.81B 2.42B 2.27B 2.07B 3.89B 268B 3.95B 26.65B 10.44B 134B 10.54B 10.31B |
| Net income | 72.16B 453M 391M 367M 334M 628M 43.3B 637M 4.3B 1.68B 21.69B 1.7B 1.66B | 63.11B 396M 342M 321M 292M 549M 37.87B 557M 3.76B 1.47B 18.97B 1.49B 1.45B |
| Net Debt | -201B -1.26B -1.09B -1.02B -931M -1.75B -121B -1.77B -11.98B -4.7B -60.45B -4.74B -4.64B | -250B -1.57B -1.35B -1.27B -1.16B -2.17B -150B -2.2B -14.88B -5.83B -75.06B -5.88B -5.76B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-18 | JP¥2,440.50 | +1.33% | 1,426,700 |
| 26-08-17 | JP¥2,408.50 | -0.88% | 1,556,000 |
| 26-08-14 | JP¥2,430.00 | +0.52% | 1,323,900 |
| 26-08-13 | JP¥2,417.50 | +0.06% | 1,481,200 |
| 26-08-12 | JP¥2,416.00 | -0.12% | 1,622,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
